This systematic review summarizes the clinical data on focal therapy (FT) when used alone as definitive therapy for primary prostate cancer (PCa).
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
The protocol is detailed in the online PROSPERO database, registration No. CRD42014014765. Articles evaluating any form of FT alone as a definitive treatment for PCa in adult male patients were included.
Of 10,419 identified articles, 10,401 were excluded, and thus leaving 18 for analysis. In total, 2288 patients were treated using seven modalities. The outcomes of FT in PCa seem to be similar to those observed with whole gland therapy and with fewer side effects.
Further research, including prospective randomized trials, is warranted to elucidate the potential advantages of focal radiation techniques for treating PCa. Prospero Registration Number: CRD42014014765.
Future oncology (London, England). 2016 Nov 04 [Epub ahead of print]
Atallah Baydoun, Bryan Traughber, Nathan Morris, Michella Abi Zeid Daou, Michael McGraw, Tarun K Podder, Raymond F Muzic, Simon S Lo, Lee E Ponsky, Mitchell Machtay, Rodney Ellis
Department of Internal Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA., Department of Radiation Oncology, Case Western Reserve University School of Medicine, Cleveland, OH, USA., Department of Epidemiology & Biostatistics, Case Western Reserve University, Cleveland, OH, USA., Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon., Cleveland Health Sciences Library, Case Western Reserve University, Cleveland, OH, USA., Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA., Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, USA., Department of Urology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.